Author: Harris, Labeeqah
Author: Mwendwa, Leah Kalekye
Similar Items: Undetected isoniazid mono resistance in rural Eastern Cape Province - A risk for the emergence of multidrug-resistant TB
- The prevalence of isoniazid and rifampicin resistance of Mycobacterium tuberculosis
- Investigating permeation of anti-mycobacterial agents in Mycobacterium tuberculosis and M. tuberculosis-infected macrophages in vitro as a model for early stage tuberculosis drug discovery
- Does the inclusion of the cost and burden of adverse drug reactions associated with drug-resistant TB treatment affect the incremental cost-effectiveness of new treatment regimens? A case study from the introduction of bedaquiline in South Africa National TB Programme
- Outcomes of patients undergoing lung resection for drug-resistant TB and the prognostic significance of pre-operative positron emission tomography/computed tomography (PET/CT) in predicting treatment failure
- Risk factors associated with isoniazid resistance in tuberculosis
- Population pharmacokinetic modelling to optimise treatment for children with Rifampicin-resistant TB and HIV
Similar Items: Genetic manipulation of mycobacterial strains using different techniques to determine the role of specific mutations associated with drug resistance
- The effects of clofazimine on mycobacterium smegmatis biofilm formation
- Gene expression changes in macrophages infected with pathogenic M. tuberculosis and non-pathogenic M. smegmatis and M. bovis BCG
- Deciphering the mechanisms of Isoniazid reisistance to mycobacterium tuberculosis
- The role of CMPK2 and RSAD2 in the killing of mycobacteria in macrophages
- The prevalence of isoniazid and rifampicin resistance of Mycobacterium tuberculosis
- Sodium, potassium adenosine triphosphatase as a potential target of the anti-tuberculosis agents, clofazimine and bedaquiline